In 2017, a routine shift in American vaccine policy created an unlikely window into the relationship between immunity and the aging heart. A large study following nearly 73,000 older adults over seven years found that those who received the newer recombinant shingles vaccine carried a measurably lower burden of cardiovascular disease than those who received the older live version — a difference of roughly nine percent overall, with stronger reductions in heart failure and ischemic heart disease. The finding does not yet prove causation, but it raises a quietly profound possibility: that a vacc